Kopran Limited (NSE:KOPRAN)

Market Cap	9.72B
Revenue (ttm)	6.30B
Net Income (ttm)	385.52M
Shares Out	n/a
EPS (ttm)	7.99
PE Ratio	25.22
Forward PE	n/a
Dividend	3.00 (1.54%)
Ex-Dividend Date	Sep 2, 2024

Volume	1,022,246
Average Volume	344,811
Open	199.80
Previous Close	200.04
Day's Range	199.80 - 212.58
52-Week Range	155.00 - 369.70
Beta	0.56
RSI	64.70
Earnings Date	May 16, 2025

About Kopran

Kopran Limited, an integrated pharmaceutical company, engages in the manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-acne, anti-infective, anti-thrombotic, antidiabetic, pa...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1958
• Employees: 842
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: KOPRAN

Financial Performance

In 2024, Kopran's revenue was 6.30 billion, an increase of 2.44% compared to the previous year's 6.15 billion. Earnings were 385.52 million, a decrease of -24.34%.